Avipoxviruses: infection biology and their use as vaccine vectors

<p>Abstract</p> <p>Avipoxviruses (APVs) belong to the <it>Chordopoxvirinae </it>subfamily of the <it>Poxviridae </it>family. APVs are distributed worldwide and cause disease in domestic, pet and wild birds of many species. APVs are transmitted by aerosols an...

Full description

Bibliographic Details
Main Authors: Tryland Morten, Weli Simon C
Format: Article
Language:English
Published: BMC 2011-02-01
Series:Virology Journal
Online Access:http://www.virologyj.com/content/8/1/49
id doaj-2519169f63604ab9ad62f5963e823e24
record_format Article
spelling doaj-2519169f63604ab9ad62f5963e823e242020-11-25T01:37:17ZengBMCVirology Journal1743-422X2011-02-01814910.1186/1743-422X-8-49Avipoxviruses: infection biology and their use as vaccine vectorsTryland MortenWeli Simon C<p>Abstract</p> <p>Avipoxviruses (APVs) belong to the <it>Chordopoxvirinae </it>subfamily of the <it>Poxviridae </it>family. APVs are distributed worldwide and cause disease in domestic, pet and wild birds of many species. APVs are transmitted by aerosols and biting insects, particularly mosquitoes and arthropods and are usually named after the bird species from which they were originally isolated. The virus species Fowlpox virus (FWPV) causes disease in poultry and associated mortality is usually low, but in flocks under stress (other diseases, high production) mortality can reach up to 50%. APVs are also major players in viral vaccine vector development for diseases in human and veterinary medicine. Abortive infection in mammalian cells (no production of progeny viruses) and their ability to accommodate multiple gene inserts are some of the characteristics that make APVs promising vaccine vectors. Although abortive infection in mammalian cells conceivably represents a major vaccine bio-safety advantage, molecular mechanisms restricting APVs to certain hosts are not yet fully understood. This review summarizes the current knowledge relating to APVs, including classification, morphogenesis, host-virus interactions, diagnostics and disease, and also highlights the use of APVs as recombinant vaccine vectors.</p> http://www.virologyj.com/content/8/1/49
collection DOAJ
language English
format Article
sources DOAJ
author Tryland Morten
Weli Simon C
spellingShingle Tryland Morten
Weli Simon C
Avipoxviruses: infection biology and their use as vaccine vectors
Virology Journal
author_facet Tryland Morten
Weli Simon C
author_sort Tryland Morten
title Avipoxviruses: infection biology and their use as vaccine vectors
title_short Avipoxviruses: infection biology and their use as vaccine vectors
title_full Avipoxviruses: infection biology and their use as vaccine vectors
title_fullStr Avipoxviruses: infection biology and their use as vaccine vectors
title_full_unstemmed Avipoxviruses: infection biology and their use as vaccine vectors
title_sort avipoxviruses: infection biology and their use as vaccine vectors
publisher BMC
series Virology Journal
issn 1743-422X
publishDate 2011-02-01
description <p>Abstract</p> <p>Avipoxviruses (APVs) belong to the <it>Chordopoxvirinae </it>subfamily of the <it>Poxviridae </it>family. APVs are distributed worldwide and cause disease in domestic, pet and wild birds of many species. APVs are transmitted by aerosols and biting insects, particularly mosquitoes and arthropods and are usually named after the bird species from which they were originally isolated. The virus species Fowlpox virus (FWPV) causes disease in poultry and associated mortality is usually low, but in flocks under stress (other diseases, high production) mortality can reach up to 50%. APVs are also major players in viral vaccine vector development for diseases in human and veterinary medicine. Abortive infection in mammalian cells (no production of progeny viruses) and their ability to accommodate multiple gene inserts are some of the characteristics that make APVs promising vaccine vectors. Although abortive infection in mammalian cells conceivably represents a major vaccine bio-safety advantage, molecular mechanisms restricting APVs to certain hosts are not yet fully understood. This review summarizes the current knowledge relating to APVs, including classification, morphogenesis, host-virus interactions, diagnostics and disease, and also highlights the use of APVs as recombinant vaccine vectors.</p>
url http://www.virologyj.com/content/8/1/49
work_keys_str_mv AT trylandmorten avipoxvirusesinfectionbiologyandtheiruseasvaccinevectors
AT welisimonc avipoxvirusesinfectionbiologyandtheiruseasvaccinevectors
_version_ 1725058576279404544